Show simple item record

Regional variation in histopathology‐specific incidence of invasive cervical cancer among Peruvian women

dc.contributor.authorPierce Campbell, Christine M.
dc.contributor.authorCurado, Maria P.
dc.contributor.authorHarlow, Siobán D.
dc.contributor.authorSoliman, Amr S.
dc.date.accessioned2017-01-10T19:10:31Z
dc.date.available2017-01-10T19:10:31Z
dc.date.issued2012-01
dc.identifier.citationPierce Campbell, Christine M.; Curado, Maria P.; Harlow, Siobán D. ; Soliman, Amr S. (2012). "Regional variation in histopathology‐specific incidence of invasive cervical cancer among Peruvian women." International Journal of Gynecology & Obstetrics 116(1): 47-51.
dc.identifier.issn0020-7292
dc.identifier.issn1879-3479
dc.identifier.urihttps://hdl.handle.net/2027.42/135622
dc.description.abstractObjectiveTo evaluate patterns of cervical cancer incidence in Peru by examining variation in 2 common histopathologic types, squamous cell carcinoma (SCC) and adenocarcinoma (ADC), and analyzing trends over time.MethodsData on the incidence of invasive cervical cancer between 1984 and 2006 were obtained from 3 population‐based cancer registries in Peru: Lima, Trujillo, and Arequipa. For each registry, data quality assessment was performed, crude and age‐specific incidence was calculated, and time trends were analyzed.ResultsOverall and SCC incidence varied across registries but incidence of ADC did not. Overall and SCC incidence showed significant declines in Trujillo (P < 0.05) and modest declines in Lima (P > 0.05) over time. ADC incidence showed marginally significant increases among women aged 15–29 years in Trujillo (P = 0.10) and modest increases among young women in Lima (P > 0.05).ConclusionPopulation‐based cancer registries were an efficient source of data for evaluating the incidence of cervical cancer once data quality had been established. Geographic and temporal variations in cervical cancer burden were documented in Peru. The trends suggest that cervical ADC is increasing among young women in urban Peru, particularly in Trujillo. We recommend supplementing current Papanicolaou test screening with complementary methods of cervical cancer control, including human papillomavirus (HPV) vaccination and HPV DNA testing.
dc.publisherIARC Press
dc.publisherWiley Periodicals, Inc.
dc.subject.otherIncidence
dc.subject.otherPeru
dc.subject.otherCervical cancer
dc.subject.otherHistopathology
dc.subject.otherEpidemiology
dc.titleRegional variation in histopathology‐specific incidence of invasive cervical cancer among Peruvian women
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelObstetrics and Gynecology
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.contributor.affiliationumDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, USA
dc.contributor.affiliationotherCancer Information Section, International Agency for Research on Cancer, Lyon, France
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/135622/1/ijgo47.pdf
dc.identifier.doi10.1016/j.ijgo.2011.08.008
dc.identifier.sourceInternational Journal of Gynecology & Obstetrics
dc.identifier.citedreferenceAlmonte M., Albero G., Molano M., Carcamo C., García P.J., Pérez G., Risk factors for human papillomavirus exposure and co‐factors for cervical cancer in Latin America and the Caribbean. Vaccine. 26 ( Suppl. 11 ): 2008; L16 – L36
dc.identifier.citedreferenceJemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D., Global cancer statistics. CA Cancer J Clin. 61 ( 2 ): 2011; 69 – 90
dc.identifier.citedreferenceFerlay J., Shin H.R., Bray F., Forman D., Mathers C., Parkin D.M., Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 127 ( 12 ): 2010; 2893 – 2917
dc.identifier.citedreferenceBoyle P., Levin B., World Cancer Report 2008. 2008; IARC Press: Lyon, France; 288 – 290
dc.identifier.citedreferenceVizcaino A.P., Moreno V., Bosch F.X., Muñoz N., Barros‐Dios X.M., Borras J., et al. International trends in incidence of cervical cancer: II. Squamous‐cell carcinoma. Int J Cancer. 86 ( 3 ): 2000; 429 – 435
dc.identifier.citedreferenceVizcaino A.P., Moreno V., Bosch F.X., Muñoz N., Barros‐Dios X.M., Parkin D.M., International trends in the incidence of cervical cancer: I. Adenocarcinoma and adenosquamous cell carcinomas. Int J Cancer. 75 ( 4 ): 1998; 536 – 545
dc.identifier.citedreferenceInternational Agency for Research on Cancer. Cancer Incidence in Five Continents Vol. IX. www.iarc.fr. http://www.iarc.fr/en/publications/pdfs‐online/epi/sp160/index.php. Published 2007
dc.identifier.citedreferenceCastellsagué X., Díaz M., de Sanjosé S., Muñoz N., Herrero R., Franceschi S., et al. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention. J Natl Cancer Inst. 98 ( 5 ): 2006; 303 – 315
dc.identifier.citedreferenceMuñoz N., Franco E.L., Herrero R., Andrus J.K., de Quadros C., Goldie S.J., et al. Recommendations for cervical cancer prevention in Latin America and the Caribbean. Vaccine. 26 ( Suppl. 11 ): 2008; L96 – L107
dc.identifier.citedreferenceMurillo R., Almonte M., Pereira A., Ferrer E., Gamboa O.A., Jerónimo J., et al. Cervical cancer screening programs in Latin America and the Caribbean. Vaccine. 26 ( Suppl. 11 ): 2008; L37 – L48
dc.identifier.citedreferenceSankaranarayanan R., Nene B.M., Shastri S.S., Jayant K., Muwonge R., Budukh A.M., et al. HPV screening for cervical cancer in rural India. N Engl J Med. 360 ( 14 ): 2009; 1385 – 1394
dc.identifier.citedreferenceDaly L., Simple SAS macros for the calculation of exact binomial and Poisson confidence limits. Comput Biol Med. 22 ( 5 ): 1992; 351 – 361
dc.identifier.citedreferencePowell J., Data sources and reporting. Jensen O.M., Parkin D.M., MacLennan R., Muir C.S., Skeet R.G.. Cancer Registration: Principles and Methods. IARC Scientific Publications No. 95. 1991; IARC Press: Lyon, France; 35
dc.identifier.citedreferenceAn H.J., Kim K.R., Kim I.S., Kim D.W., Park M.H., Park I.A., et al. Prevalence of human papillomavirus DNA in various histological subtypes of cervical adenocarcinoma: a population‐based study. Mod Pathol. 18 ( 4 ): 2005; 528 – 534
dc.identifier.citedreferenceInternational Collaboration of Epidemiological Studies of Cervical Cancer. Comparison of risk factors for invasive squamous cell carcinoma and adenocarcinoma of the cervix: collaborative reanalysis of individual data on 8,097 women with squamous cell carcinoma and 1,374 women with adenocarcinoma from 12 epidemiological studies. Int J Cancer. 120 ( 4 ): 2007; 885 – 891
dc.identifier.citedreferenceSmith H.O., Tiffany M.F., Qualls C.R., Key C.R., The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States—a 24‐year population‐based study. Gynecol Oncol. 78 ( 2 ): 2000; 97 – 105
dc.identifier.citedreferenceLiu S., Semenciw R., Probert A., Mao Y., Cervical cancer in Canada: changing patterns in incidence and mortality. Int J Gynecol Cancer. 11 ( 1 ): 2001; 24 – 31
dc.identifier.citedreferenceBray F., Carstensen B., Møller H., Zappa M., Zakelj M.P., Lawrence G., et al. Incidence trends of adenocarcinoma of the cervix in 13 European countries. Cancer Epidemiol Biomarkers Prev. 14 ( 9 ): 2005; 2191 – 2199
dc.identifier.citedreferenceMartins E., Curado M.P., Freitas N.M., de Oliveira J.C., Freitas R. Jr.. Increase in cervical adenocarcinoma rate in Goiânia, GO, Brazil. Int J Gynecol Cancer. 19 ( 4 ): 2009; 694 – 698
dc.identifier.citedreferenceKrane J.F., Granter S.R., Trask C.E., Hogan C.L., Lee K.R., Papanicolaou smear sensitivity for the detection of adenocarcinoma of the cervix: a study of 49 cases. Cancer. 93 ( 1 ): 2001; 8 – 15
dc.identifier.citedreferenceRaab S.S., Can glandular lesions be diagnosed in pap smear cytology?. Diagn Cytopathol. 23 ( 2 ): 2000; 127 – 133
dc.identifier.citedreferenceParkin D.M., Bray F., Evaluation of data quality in the cancer registry: principles and methods Part II. Completeness. Eur J Cancer. 45 ( 5 ): 2009; 756 – 764
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.